Stockholders' Equity - Schedule of Restricted Stock Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares
Number of Shares
Outstanding at beginning of period (in shares) | shares		49,600
Granted (in shares) | shares		76,268
Vested (in shares) | shares		(19,902)
Outstanding at end of period (in shares) | shares	105,966	105,966
Weighted- average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares		$ 12.00
Granted (in dollars per share) | $ / shares		12.47
Vested (in dollars per share) | $ / shares		10.79
Outstanding at end of period (in dollars per share) | $ / shares	$ 12.57	$ 12.57
Stock based compensation expense | $		$ 563
Compensation cost not yet recognized | $	$ 700	$ 700
Unvested restricted stock
Number of Shares
Outstanding at beginning of period (in shares) | shares		0
Granted (in shares) | shares		18,200
Vested (in shares) | shares
Outstanding at end of period (in shares) | shares	18,200	18,200
Weighted- average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares
Granted (in dollars per share) | $ / shares		16.41
Vested (in dollars per share) | $ / shares
Outstanding at end of period (in dollars per share) | $ / shares	$ 16.41	$ 16.41
Stock based compensation expense | $	$ 39
Compensation cost not yet recognized | $	$ 260	$ 260